Valuation BioHarvest Sciences Inc. Canadian Securities Exchange
Stocks
BHSC
CA13767B1013
Pharmaceuticals
|
Delayed
Canadian Securities Exchange
15:24:58 05/10/2021 BST
|
5-day change | 1st Jan Change | ||
| 0.3500 CAD | +6.06% |
|
-2.94% | +46.67% |
| 08-11 | BioHarvest Sciences Inc., Q2 2026 Earnings Call, Aug 11, 2026 | |
| 08-11 | BioHarvest Sciences Inc. Revises Consolidated Earnings Guidance for the Fiscal Year 2026 | CI |
Company Valuation: BioHarvest Sciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 75.75 | 107.1 | 117.6 | 46.02 | - | - |
| Change | - | 41.36% | 9.8% | -60.86% | - | - |
| Enterprise Value (EV) | 75.75 | 107.1 | 117.6 | 46.02 | 46.02 | 46.02 |
| Change | - | 41.36% | 9.8% | -60.86% | 0% | 0% |
| P/E | -5.28x | -7.73x | -8.65x | -3.85x | -6.06x | 15.6x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0.3x | 0.3x | 0.3x | 0.2x | -0x |
| Capitalization / Revenue | - | 4.25x | 3.41x | 1.23x | 0.93x | 0.64x |
| EV / Revenue | - | 0x | 0x | 1.23x | 0.93x | 0.64x |
| EV / EBITDA | - | -0x | -0x | -6.04x | -12.6x | 9.61x |
| EV / EBIT | - | -0x | -0x | -5.13x | -9.45x | 8.28x |
| EV / FCF | - | -0x | -0x | -3.9x | -3.49x | 10.7x |
| FCF Yield | - | -8.89% | -8.15% | -25.6% | -28.6% | 9.31% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.05 | -0.8 | -0.6 | -0.5275 | -0.335 | 0.13 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 25.19 | 34.51 | 37.42 | 49.59 | 71.53 |
| EBITDA 1 | - | -5.738 | -3.951 | -7.618 | -3.641 | 4.786 |
| EBIT 1 | - | -6.989 | -5.575 | -8.977 | -4.87 | 5.555 |
| Net income 1 | -12.56 | -12.91 | -11.14 | -12.02 | -7.648 | 3.409 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 5.539 | 6.180 | 5.190 | 2.030 | 2.030 | 2.030 |
| Nbr of stocks (in thousands) | 13,677 | 17,328 | 22,654 | 22,668 | - | - |
| Announcement Date | 30/04/24 | 31/03/25 | 31/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.69x | 1.87x | 12.63x | 5.46% | 13.19B | |
| 22.49x | 1.44x | 8.66x | 2.83% | 4.9B | |
| 16.77x | 3.45x | 10.71x | 5.48% | 4.91B | |
| 18.34x | - | - | 1.27% | 4.1B | |
| 26.6x | - | - | - | 3.53B | |
| 16.94x | 2.39x | 10.38x | 2.95% | 3.38B | |
| Average | 19.47x | 2.29x | 10.59x | 3.6% | 5.67B | |
| Weighted average by Cap. | 18.40x | 2.15x | 11.24x | 4.2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BHST Stock
- BHSC Stock
- Valuation BioHarvest Sciences Inc.
Select your edition
All financial news and data tailored to specific country editions
